Eli Lilly's shares dipped slightly after reaching a record high, buoyed by positive analyst commentary and strong financial performance. Analysts continue to raise price targets amid regulatory and competitive challenges.
Mike Clair
Jul 09, 2026
IBM shares fell 1.6% amid AI investment concerns and market volatility, despite the company's focus on hybrid cloud and quantum computing innovations.
Scott Lance
Jul 09, 2026
Dell Technologies' stock has surged over 220% in 2026, driven by AI server demand and endorsements from President Trump, despite potential short-term volatility and market resistance.
George Anton
Jul 09, 2026
South Australian drivers are encouraged to use real-time fuel price apps to save money, following a compliance blitz that fined petrol stations nearly $20,000 for inaccurate pricing.
Tony Jackson
Jul 09, 2026
Kingsoft Cloud's shares rose 10.70% amid volatility, driven by its expanding AI infrastructure business. Analysts remain bullish, citing strong revenue growth and strategic partnerships.
George Anton
Jul 09, 2026
Penguin Solutions' shares rose sharply after reporting record third-quarter earnings and raising full-year guidance, driven by strong AI infrastructure demand and a new Nvidia partnership.
Mike Clair
Jul 09, 2026
South Korea's KOSPI index nearly doubled in 2026, driven by a semiconductor boom. Key companies like Samsung and SK Hynix lead the rally, but volatility and risks remain significant.
Tony Jackson
Jul 09, 2026
GameStop shareholders approved governance changes to facilitate the company's pursuit of eBay, despite eBay's initial rejection. The move aims to enhance GameStop's strategic flexibility in acquisitions.
Tony Jackson
Jul 09, 2026
The Russell 2000 index fell nearly 1% as small-cap stocks faced pressure from investor caution over interest rates, economic growth signals, and shifting market sentiment.
Scott Lance
Jul 08, 2026
The Nasdaq Composite fell amid geopolitical tensions and tech sector volatility, with oil prices surging due to renewed Middle East conflicts. Technology stocks showed resilience despite broader market declines.
Tony Jackson
Jul 08, 2026
U.S. stocks fell sharply as President Trump declared the U.S.-Iran ceasefire over, escalating geopolitical tensions and causing oil prices to surge, impacting global markets and investor sentiment.
Mike Clair
Jul 08, 2026
South Korea's KOSPI index fell sharply due to a selloff in semiconductor stocks, despite strong earnings from Samsung Electronics. The decline reflects investor concerns over AI investment sustainability.
Scott Lance
Jul 08, 2026
The FTSE 100 index fell sharply due to escalating Middle East tensions, impacting oil prices and investor sentiment. Despite recent gains, the index faces potential volatility amid geopolitical risks.
Tony Jackson
Jul 08, 2026
Anthropic's Claude Cowork tool is now available on mobile and web, enabling seamless task management across devices and enhancing productivity for general business operations.
Scott Lance
Jul 08, 2026
OpenAI is launching its GPT-5.6 AI models, including Sol, Terra, and Luna, amid U.S.-China tech tensions and security concerns, following a limited preview and government evaluations.
George Anton
Jul 08, 2026
Vertex Pharmaceuticals is set to acquire Crinetics Pharmaceuticals for $10 billion, enhancing its endocrinology portfolio with key assets like Palsonify and atumelnant, pending regulatory approvals.
Scott Lance
Jul 08, 2026
Santos Ltd shares rose 5.78% as Middle East tensions escalated, boosting oil prices. The company's stock gains reflect broader energy market volatility and ongoing takeover speculation.
Tony Jackson
Jul 08, 2026
Samsung's Galaxy Unpacked event in London will showcase new foldable phones, wearables, and a preview of smart glasses, with early reservation savings available for prospective buyers.
George Anton
Jul 08, 2026
Iran launched missile and drone attacks on U.S. sites in Bahrain and Kuwait after U.S. airstrikes in Iran, escalating tensions and impacting global oil prices.
Anthony Will
Jul 08, 2026
Commonwealth Bank of Australia shares have shown a steady recovery, trading at $168.18, despite being down over the past year. Analysts remain cautiously optimistic about the bank's future prospects.
Tony Jackson
Jul 08, 2026
Australian shares fell for a third session, with the ASX 200 down 0.66%, impacted by global semiconductor weakness and a sell-off in lithium and rare earth stocks.
Tony Jackson
Jul 08, 2026
Samsung Electronics reported a record $58 billion profit in Q2, driven by soaring memory chip prices amid global AI expansion, surpassing previous records set by Nvidia and Apple.
George Anton
Jul 08, 2026
Leaked information suggests Google's Pixel 11 series will feature higher prices but increased base storage, starting at 256GB. The series may also include new camera upgrades and a Tensor G6 chip.
George Anton
Jul 08, 2026
Microsoft Teams users reported access issues, with conflicting outage reports from monitoring services. Microsoft has not confirmed an outage, leaving users uncertain about the platform's status.
George Anton
Jul 08, 2026
Nvidia shares fell as Chinese AI company DeepSeek develops its own semiconductor, potentially reducing reliance on Nvidia and Huawei chips. The move highlights growing competition in AI computing.
Tony Jackson
Jul 08, 2026
Netflix shares rose 1.72% after a challenging year marked by a failed Warner Bros. acquisition. Investors await the company's upcoming earnings report for further insights.
Mike Clair
Jul 08, 2026
GameStop is evolving from a traditional retailer to a diversified player, focusing on e-commerce and strategic initiatives amid industry shifts and market volatility.
George Anton
Jul 08, 2026
SpaceX shares fell 5.77% as investors evaluated post-IPO volatility and awaited updates on the Starship program. The decline highlights ongoing challenges and opportunities in the space economy.
Jerry Thompson
Jul 08, 2026
Maase Inc.'s shares rose 15.74% as the company shifts from financial services to AI infrastructure, highlighting significant stock volatility and strategic acquisitions.
Mike Clair
Jul 08, 2026
Agios Pharmaceuticals' stock surged after the FDA granted priority review to its drug mitapivat for sickle cell disease, potentially accelerating its market entry and expanding its commercial reach.
Jerry Thompson
Jul 08, 2026
